Minimal Residual Disease Assessment in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Is it Ready for Routine Clinical Practice?
There is a continuing need to educate clinicians about the current methods used for the detection of MRD and the prognostic significance of undetectable MRD in patients with CLL. This will also aid in the successful implementation of MRD testing when it becomes readily accessible for use in routine clinical setting.
Optimizing Treatment Approaches for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
The use of targeted therapies as a preferred treatment approach for newly diagnosed chronic lymphocytic leukemia (CLL) has significantly transformed the treatment landscape of relapsed/refractory disease. Clinicians are challenged to remain up-to-date about the recent clinical advances that can help them make informed clinical decisions for individual patients to optimize clinical outcomes.
NCCN Guidelines® Insights - Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 3.2022
These NCCN Guidelines Insights discuss the updates to the NCCN Guidelines for CLL/SLL specific to the use of chemotherapy-free treatment options for patients with treatment-naïve and relapsed/refractory disease.
Case 4: Relapsed CLL/SLL with del(17p)/TP53 mutation and ibrutinib intolerance in a patient ≥65 years
Earn CME/CE while testing your knowledge. Try your skills at this challenging case in CLL/SLL.
Case 3: Relapsed CLL/SLL without del(17p)/TP53 mutation in a patient ≥65 years
Earn CME/CE while testing your knowledge. Try your skills at this challenging case in CLL/SLL.
Case 2: Newly Diagnosed CLL/SLL with del(17p)/TP53 mutation
Earn CME/CE while testing your knowledge. Try your skills at this challenging case in CLL/SLL.
Case 1: Newly Diagnosed CLL/SLL without del(17p)/TP53 mutation in a patient <65 years without significant comorbidities
Earn CME/CE while testing your knowledge. Try your skills at this challenging case in CLL/SLL.
Applying Guideline Updates and Real-World Experience in CLL: Experts Review State-of-the-Art Evidence and Address Clinical Challenges
The goal of this activity is to improve the knowledge, confidence, and performance of learners to integrate recent findings into the treatment of patients with CLL/SLL.
Guideline Updates and Real-World Experiences in CLL: State-of-the-Art Evidence and Next Questions
The goal of this activity is to improve the knowledge, confidence, and performance of learners to integrate recent findings into the treatment of patients with CLL/SLL.
Guideline Updates and Real-World Experiences in CLL: State-of-the-Art Evidence and Next Questions
The goal of this activity is to improve the knowledge, confidence, and performance of learners to integrate recent findings into the treatment of patients with CLL/SLL.

Pages

Subscribe to RSS - Chronic Lymphocytic Leukemia